Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.81 USD | +0.52% | -7.19% | -25.89% |
04-08 | North American Morning Briefing : Inflation Data, -2- | DJ |
04-05 | Oppenheimer Upgrades AngioDynamics to Outperform From Perform, $12 Price Target | MT |
Sales 2024 * | 287M 393M | Sales 2025 * | 287M 393M | Capitalization | 233M 318M |
---|---|---|---|---|---|
Net income 2024 * | -194M -265M | Net income 2025 * | -43M -58.78M | EV / Sales 2024 * | 0.81 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.81 x |
P/E ratio 2024 * |
-1.26
x | P/E ratio 2025 * |
-6.53
x | Employees | 815 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.13% |
Latest transcript on AngioDynamics, Inc.
1 day | +0.52% | ||
1 week | -7.19% | ||
Current month | -1.02% | ||
1 month | +7.59% | ||
3 months | -3.49% | ||
6 months | -6.29% | ||
Current year | -25.89% |
Managers | Title | Age | Since |
---|---|---|---|
James Clemmer
CEO | Chief Executive Officer | 60 | 16-03-31 |
Director of Finance/CFO | 49 | 08-05-31 | |
Juan Serna
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jan Reed
BRD | Director/Board Member | 64 | 16-11-08 |
Howard Donnelly
CHM | Chairman | 63 | 04-02-29 |
Wesley Johnson
BRD | Director/Board Member | 65 | 07-01-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 27 M€ | -5.03% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 5.81 | +0.52% | 313,347 |
24-04-25 | 5.78 | -1.53% | 373,060 |
24-04-24 | 5.87 | -2.65% | 586,457 |
24-04-23 | 6.03 | -3.67% | 379,009 |
24-04-22 | 6.26 | 0.00% | 336,227 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.89% | 233M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- ANGO Stock